WOODRIDGE, Ill., Sept. 11 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS - News), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and inflammation made an oral presentation and presented a poster at the 232nd American Chemical Society National Meeting. This year’s meeting is taking place in San Francisco, California, from September 10 through September 14, 2006. More than 12,500 scientists are expected to attend the Fall meeting. The Company’s presentations detailed research on the chemical synthesis and apoptotic activity of caspase-activating pentacyclic triterpenoids.
